on Mallia Innovations
Mallia Explores sCD83's Potential at FUE Europe Meeting
Mallia Aesthetics is set to present the potential of the soluble protein CD83 (sCD83) for hair transplantation at the FUE Europe Meeting in Madrid. As the Platinum Sponsor, the company will showcase their research on sCD83's ability to stimulate hair follicles and aid in post-surgery wound healing.
Prof. Dr. Alexander Steinkasserer will lead the presentation, detailing the molecule's immunomodulatory properties. These have shown promise in activating hair growth phases and promoting wound recovery. Mallia plans to launch two sCD83-based 8T3 ProLine products for medical professionals by Q4 2025.
FUE Europe Meeting, a significant event for hair transplant specialists, brings together experts to discuss advanced methods like Follicular Unit Extraction. Mallia's participation underscores its commitment to scientific innovation and offering hormone-free solutions for hair growth.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Mallia Innovations news